Diabetes and COVID-19: The past, the present, and the future
| Autor: | Sherly Lawrensia, Raymond Pranata, Ian Huang, Wilson M. Raffaello, Joshua Henrina |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Blood Glucose medicine.medical_specialty Telemedicine COVID-19 Vaccines Endocrinology Diabetes and Metabolism Population Blood sugar 030209 endocrinology & metabolism Type 2 diabetes Article 03 medical and health sciences 0302 clinical medicine Endocrinology Internal medicine Diabetes mellitus Pandemic medicine Humans Hypoglycemic Agents Mortality Intensive care medicine education Pandemics education.field_of_study business.industry SARS-CoV-2 Blood Glucose Self-Monitoring Diabetes COVID-19 medicine.disease Dilemma 030104 developmental biology Diabetes Mellitus Type 1 Diabetes Mellitus Type 2 Observational study Disease Susceptibility Morbidity business |
| Zdroj: | Metabolism |
| ISSN: | 1532-8600 0026-0495 |
| Popis: | Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since the worse outcomes are closely associated with higher blood sugar levels in COVID-19 infection. Although recent observational studies showed that insulin was associated with mortality, it should not deter insulin use in hospitalized patients requiring tight glucose control. Back and forth dilemma in the past with regards to continue/discontinue certain medications used in diabetes have been mostly resolved. The initial fears of consequences related to continuing certain medications have been largely dispelled. COVID-19 also necessitates the transformation in diabetes care through the integration of technologies. Recent advances in health-related technologies, notably telemedicine and remote continuous glucose monitoring, have become essential in the management of diabetes during the pandemic. Today, these technologies have changed the landscape of medicine and become more important than ever. Being a high-risk population, patients with type 1 or type 2 diabetes, should be prioritized for vaccination. In the future, as the pandemic fades, the prevalence of non-communicable diseases is expected to rise due to lifestyle changes and medical issues/dilemma encountered during the pandemic. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect